Exchange & Visit
Director of Scottish Centre for Regenerative Medicine Sir Ian Wilmut Visited SARI
date：
2010-08-27
Shanghai, China - August 25, 2010 - Sir Ian Wilmut, Director of Scottish Centre for Regenerative Medicine, visited Shanghai Advanced Research Institute of Chinese Academy of Sciences (SARI), together with Chief Operating Office of the Center Bruce Whitelaw, President of Linx Pharmaceutical Co.,Ltd Xu Xiaochun and Edinburgh University Representative in China Nini Yang. President of SARI Feng Songlin, Vice President JiangBiao and Director of Nano-Medicine and Transfer Research Center Guo Fang met the visitors and arranged a meeting.
On behalf of SARI, President Feng Songlin welcomed Sir Ian Wilmut, et al. Vice President JiangBiao briefly introduced the preparation progress of SARI, the construction of the Pu Dong Science and Technology Park, SARI’s Research Areas and International Cooperation Initiatives. Director Guo Fang made a presentation on the present status and future development plans of the Nano-Medicine and Tranfer Research Center. The SARI team then discussed with Sir Ian Wilmut, et al regarding the potential cooperation areas, such as stem cell research, medicine transfer and medicine research and development. After the meeting, Prof. Guofang and Sir Ian Wilmut, et al visited the construction site of Pu Dong Science and Technology Park.
Sir Ian Wilmut is best known as the leader of the research group that in 1996 first cloned a mammal from an adult somatic cell, a Finnish Dorset lamb named Dolly. Dr. Wilmut is an English embryologist and has a distinguished record of ground-breaking biological research. In 2000, he was elected a Fellow of the Royal Society of Edinburgh, and in the previous year was made a member of the Order of the British Empire by Queen Elizabeth II. Other awards include a fellowship in the Academy of Medical Sciences, the Lord Lloyd of Kilgerran Prize, etc. He was knighted in 2008.
On behalf of SARI, President Feng Songlin welcomed Sir Ian Wilmut, et al. Vice President JiangBiao briefly introduced the preparation progress of SARI, the construction of the Pu Dong Science and Technology Park, SARI’s Research Areas and International Cooperation Initiatives. Director Guo Fang made a presentation on the present status and future development plans of the Nano-Medicine and Tranfer Research Center. The SARI team then discussed with Sir Ian Wilmut, et al regarding the potential cooperation areas, such as stem cell research, medicine transfer and medicine research and development. After the meeting, Prof. Guofang and Sir Ian Wilmut, et al visited the construction site of Pu Dong Science and Technology Park.
Sir Ian Wilmut is best known as the leader of the research group that in 1996 first cloned a mammal from an adult somatic cell, a Finnish Dorset lamb named Dolly. Dr. Wilmut is an English embryologist and has a distinguished record of ground-breaking biological research. In 2000, he was elected a Fellow of the Royal Society of Edinburgh, and in the previous year was made a member of the Order of the British Empire by Queen Elizabeth II. Other awards include a fellowship in the Academy of Medical Sciences, the Lord Lloyd of Kilgerran Prize, etc. He was knighted in 2008.
Copyright Shanghai Advanced Research Institute, Chinese Academy of Sciences J ICP No. 05002857
Address: No.99 Haike Road, Zhangjiang Hi-Tech Park, Pudong Shanghai,P R China| Phone：021-20325000 | Email：sari@sari.ac.cn
